IKE(Imidazole ketone erastin)

Synonyms: PUN30119

IKE(Imidazole ketone erastin) is a potent, selective, and metabolically stable system xc– inhibitor and inducer of ferroptosis.

IKE(Imidazole ketone erastin) Chemical Structure

IKE(Imidazole ketone erastin) Chemical Structure

CAS No. 1801530-11-9

Purity & Quality Control

Products often used together with IKE(Imidazole ketone erastin)

Rapamycin


Imidazole ketone erastin and Rapamycin induce cell death in acute lymphoblastic leukemia (ALL) cell lines Jurkat/CCRF-CEM/CEM/C1/Nalm6/Sup-B15/THP-1/HL-60.


Zhu T, et al. Front Cell Dev Biol. 2021 Nov 15;9:740884.

IKE(Imidazole ketone erastin) Related Products

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
BJeLR Growth inhibition assay 48 hrs Growth inhibition of human RAS-G12V overexpressing BJeLR cells after 48 hrs by alamar blue assay, IC50 = 0.003 μM. 26231156
CCF-STTG1 Function assay 2 hrs Inhibition of Xct in human CCF-STTG1 cells assessed as glutamate release after 2 hrs by fluorometry, IC50 = 0.03 μM. 26231156
HT1080 Growth inhibition assay 48 hrs Growth inhibition of human HT1080 cells after 48 hrs by alamar blue assay, GI50 = 0.314 μM. 26231156
DRD Growth inhibition assay 48 hrs Growth inhibition of human RAS-G12V overexpressing DRD cells after 48 hrs by alamar blue assay 26231156
Click to View More Cell Line Experimental Data

Biological Activity

Description IKE(Imidazole ketone erastin) is a potent, selective, and metabolically stable system xc– inhibitor and inducer of ferroptosis.
Targets
Ferroptosis [1] system xc– [1]
In vitro
In vitro

Imidazole ketone erastin (IKE) is an erastin analog with nanomolar potency, high metabolic stability, and intermediate water solubility. Its treatment potently reduces DLBCL cell number[1].

Cell Research Cell lines DLBCL cell line
Concentrations 0-100 μM
Incubation Time 24 h
Method

DLBCL cells are plated at 10,000 cells per well in white 384-well plates (32 μL per well) in technical duplicates and incubated overnight. The cells are then treated with 8 μL medium containing a two-fold dilution series of vehicle (DMSO), IKE (starting from 100 μM) with or without Fer-1 (starting from 200 μM). After 24 h incubation, 40 μL of 50% CellTiter-Glo / 50% cell culture medium is added to each well and incubated at room temperature with shaking for 15 min. Luminescence is measured. All cell viability data are normalized to the DMSO vehicle condition. Experiments are performed three independent times with different passages for each cell line. From these data, dose-response curves and IC50 values are computed.

Experimental Result Images Methods Biomarkers Images PMID
Growth inhibition assay Cell viability 30799221
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01555008 Completed
Type 2 Diabetes Mellitus|Renal Impairment
Lexicon Pharmaceuticals
March 2012 Phase 1
NCT04545450 Completed
Transgenderism|Hypogonadism
Unita Complessa di Ostetricia e Ginecologia
November 4 2008 Phase 3

Chemical Information & Solubility

Molecular Weight 655.14 Formula

C35H35ClN6O5

CAS No. 1801530-11-9 SDF --
Smiles CC(C)OC1=C(C=C(C=C1)C(=O)CN2C=CN=C2)N3C(=NC4=CC=CC=C4C3=O)CN5CCN(CC5)C(=O)COC6=CC=C(C=C6)Cl
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 100 mg/mL ( (152.63 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy IKE(Imidazole ketone erastin) | IKE(Imidazole ketone erastin) supplier | purchase IKE(Imidazole ketone erastin) | IKE(Imidazole ketone erastin) cost | IKE(Imidazole ketone erastin) manufacturer | order IKE(Imidazole ketone erastin) | IKE(Imidazole ketone erastin) distributor